Abstract:BACKGROUND: The heterogeneity of mesenchymal stem cells (MSCs) is poorly understood, thus limiting clinical application and basic research reproducibility. Advanced single-cell RNA sequencing (scRNA-seq) is a robust tool used to analyse for dissecting cellular heterogeneity. However, the comprehensive single-cell atlas for human MSCs has not been achieved.METHODS: This study used massive parallel multiplexing scRNA-seq to construct an atlas of > 130 000 single-MSC transcriptomes across multiple tissues and donors to assess their heterogeneity. The most widely clinically utilised tissue resources for MSCs were collected, including normal bone marrow (n = 3), adipose (n = 3), umbilical cord (n = 2), and dermis (n = 3).RESULTS: Seven tissue-specific and five conserved MSC subpopulations with distinct gene-expression signatures were identified from multiple tissue origins based on the high-quality data, which has not been achieved previously. This study showed that extracellular matrix (ECM) highly contributes to MSC heterogeneity. Notably, tissue-specific MSC subpopulations were substantially heterogeneous on ECM-associated immune regulation, antigen processing/presentation, and senescence, thus promoting inter-donor and intra-tissue heterogeneity. The variable dynamics of ECM-associated genes had discrete trajectory patterns across multiple tissues. Additionally, the conserved and tissue-specific transcriptomic-regulons and protein-protein interactions were identified, potentially representing common or tissue-specific MSC functional roles. Furthermore, the umbilical-cord-specific subpopulation possessed advantages in immunosuppressive properties.CONCLUSION: In summary, this work provides timely and great insights into MSC heterogeneity at multiple levels. This MSC atlas taxonomy also provides a comprehensive understanding of cellular heterogeneity, thus revealing the potential improvements in MSC-based therapeutic efficacy.

Developmental definition of MSCs: new insights into pending questions.

Mscs Identification

Mesenchymal Stem Cell Preparations—Comparing Apples and Oranges

[Advances of Studies on Mesenchymal Stem Cells].

Mesenchymal Stem Cell Subpopulations: Phenotype, Property and Therapeutic Potential.

Dissecting Heterogeneity Reveals a Unique BAMBIhighMFGE8high Subpopulation of Human UC-MSCs

Concise Review: Mesenchymal Stem Cells Derived from Human Pluripotent Cells, an Unlimited and Quality-Controllable Source for Therapeutic Applications

Single-cell Transcriptomic Analysis Reveals the Cellular Heterogeneity of Mesenchymal Stem Cells

Mesenchymal stem cell perspective: cell biology to clinical progress

Mesenchymal Stem Cells – Sources and Clinical Applications

Adipogenic Placenta-Derived Mesenchymal Stem Cells Are Not Lineage Restricted by Withdrawing Extrinsic Factors: Developing a Novel Visual Angle in Stem Cell Biology

Characterization of mesenchymal stem cells in human fetal bone marrow by single-cell transcriptomic and functional analysis

Mesenchymal stem cells lineage and their role in disease development

Mesenchymal stem cells: Cell therapy and regeneration potential

Isolation, cultivation, and characterization of human mesenchymal stem cells

Cross-Tissue Characterization of Heterogeneities of Mesenchymal Stem Cells and Their Differentiation Potentials

[Mesenchymal stem cells: definitions, culture and potential applications]

Mesenchymal Stem Cells: Molecular Characteristics and Clinical Applications

Concise Review: Mesenchymal Stem Cells: From Roots to Boost

Molecular Characterization of Heterogeneous Mesenchymal Stem Cells with Single-Cell Transcriptomes.

Single‐cell transcriptome atlas of human mesenchymal stem cells exploring cellular heterogeneity